Humacyte, Inc. (NASDAQ:HUMA) Q4 2022 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Fourth Quarter and Year-End 2022 Results Conference Call. Currently, all participants are in a listen-only mode.

Related Keywords

Munich ,Bayern ,Germany ,United States ,Israel ,Ukraine ,Israeli ,Ukrainian ,American ,Alan Kypson ,Heather Prichard ,Oleksandr Stanko ,Ryan Zimmerman ,Lauren Marek ,Laura Niklason ,Dale Sander ,Vasyl Shaprynsky ,Alexander Sokolov ,Diabetes Research Foundation ,Nasdaq ,Corporate Development ,Alpha Healthcare Acquisition Corp ,Humacyte Inc ,American Heart Association Scientific Sessions ,Call Transcript March ,Humacyte Fourth Quarter ,Chief Executive Officer ,Chief Financial Officer ,Chief Corporate Development Officer ,Chief Operating ,Human Acellular ,Vascular Surgeons ,Munich Vascular Conference ,Peripheral Arterial Disease ,Vascular Surgery ,Juvenile Diabetes Research Foundation ,Biovascular Pancreas ,Alpha Healthcare Acquisition ,Visited Countries ,